On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
MondayMar 13, 2017 1:30 pm

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) Starts Presentation at 29th Annual ROTH Conference

Foamix Pharmaceuticals (NASDAQ: FOMX) is a specialty pharmaceutical company focused on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. The company’s clinical stage product candidates include FMX101, a novel minocycline foam for the treatment of moderate-to-severe acne; FMX103 for the treatment of moderate-to-severe rosacea; FMX102 for the treatment of impetigo; and FDX104, a doxycycline foam for the management of acne-like rash induced by EGFRI anticancer drugs. In addition, Foamix has development and license agreements relating to its technology with various pharmaceutical companies including Bayer HealthCare and others. For more information, visit the company’s website…

Continue Reading

MondayMar 13, 2017 1:25 pm

ORHub, Inc.’s (ORHB) Surgical Resource Management Platform Aims to Revolutionize Surgical Care

With health care costs constantly on the rise across all medical sectors, a growing number of health care professionals and practices are looking for ways to streamline and improve their processes via electronic management technologies, so as to ultimately offer more efficient and cost-effective services. Whether it’s electronic medical records, revenue cycle management, scheduling and billing software, or more, cloud-based technologies are becoming increasingly popular in the health care niche, proving to be a very effective replacement for the traditional manual systems. One segment that is largely unaddressed, but which would particularly benefit from a more complex and comprehensive digital…

Continue Reading

MondayMar 13, 2017 1:00 pm

Aduro BioTech, Inc. (NASDAQ: ADRO) Starts Presentation at 29th Annual ROTH Conference

Aduro Biotech (NASDAQ: ADRO) is an immunotherapy company focused on the discovery, development and commercialization of therapies that transform the treatment of challenging diseases. Aduro's technology platforms, which are designed to harness the body's natural immune system, are being investigated in cancer indications and have the potential to expand into autoimmune and infectious diseases. Aduro's LADD technology platform is based on proprietary attenuated strains of Listeria that have been engineered to express tumor-associated antigens to induce specific and targeted immune responses and is being developed as a treatment for multiple indications, including ovarian, lung and prostate cancers, and mesothelioma. Additionally,…

Continue Reading

MondayMar 13, 2017 1:00 pm

Align Technology, Inc. (NASDAQ: ALGN) Starts Presentation at 29th Annual ROTH Conference

Align Technology (NASDAQ: ALGN) is provider of clear aligner orthodontics that designs, manufactures and markets the Invisalign® system, which provides dental professionals with a range of  treatment options for adults and teenagers. Align also offers the iTero 3D digital scanning system and services for orthodontic and restorative dentistry. Align was founded in March 1997 and received FDA clearance to market the Invisalign system in 1998. For more information, visit the company’s website at www.aligntech.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and…

Continue Reading

MondayMar 13, 2017 1:00 pm

UniPixel, Inc. (NASDAQ: UNXL) Starts Presentation at 29th Annual Roth Conference

UniPixel (NASDAQ: UNXL) designs, develops, manufactures and markets micro-structured polymer film materials and related technologies for the display, flexible electronics, and automotive industries in the United States. It makes innovative performance-engineered films that enhance and protect touchscreen and flexible electronics products. The company markets its touch screen films under the brand XTouch, as sub-components of a touch sensor module; and hard coat resin and optical films under the Diamond Guard brand. Uni-Pixel Inc. was founded in 1998 and is headquartered in Santa Clara, California. For more information, visit the company’s website at www.unipixel.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation…

Continue Reading

MondayMar 13, 2017 1:00 pm

Attunity, Ltd. (NASDAQ: ATTU) Starts Presentation at 29th Annual ROTH Conference

Attunity (NASDAQ: ATTU) provides data integration and big data management software solutions that enable availability, delivery, and, management of data across heterogeneous enterprise platforms, organizations, and the cloud. The company’s software solutions include data replication and distribution, test data management, change data capture, data connectivity, enterprise file replication, managed file transfer, data warehouse automation, data usage analytics, and cloud data delivery. Headquartered in Boston, Attunity serves its customers via offices in North America, Europe, and Asia Pacific and through a network of local partners. For more information, visit the company’s website at www.attunity.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As…

Continue Reading

MondayMar 13, 2017 1:00 pm

BioPharmX Corp. (NYSE: BPMX) Starts Presentation at 29th Annual ROTH Conference

BioPharmX (NYSE: BPMX) is a Silicon Valley-based specialty pharmaceutical company that seeks to provide products through proprietary platform technologies for prescription, over-the-counter and supplement applications in dermatology, aesthetics and women's health. The company’s product pipeline includes Violet®, the company’s initial direct-to-consumer product; BPX-01, currently in phase 2 of clinical development; and BPX-03, currently in phase 3 with regulatory filings in progress. For more information, visit the company’s website at www.BioPharmX.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an…

Continue Reading

MondayMar 13, 2017 1:00 pm

DMC Global, Inc. (NASDAQ: BOOM) Starts Presentation at 29th Annual ROTH Conference

DMC Global (NASDAQ: BOOM) is a Boulder, Colorado based company that operates in two sectors: industrial infrastructure and oilfield products and services. The industrial infrastructure sector is served by DMC's NobelClad business, the world's largest manufacturer of explosion-welded clad metal plates, which are used to fabricate capital equipment utilized within various process industries and other industrial sectors. The oilfield products and services sector is served by DynaEnergetics, an international developer, manufacturer and marketer of advanced explosive components and systems used to perforate oil and gas wells. For more information, visit the company’s website at www.dmcglobal.com. About NetworkNewsWire NetworkNewsWire (NNW) provides…

Continue Reading

MondayMar 13, 2017 12:30 pm

Glaukos Corp. (NYSE: GKOS) Starts Presentation at 29th Annual ROTH Conference

Glaukos (NYSE: GKOS) is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, one of the world’s leading causes of blindness. The company pioneered Micro-Invasive Glaucoma Surgery (MIGS) to revolutionize the traditional glaucoma treatment and management paradigm. Glaukos launched the iStent®, its first MIGS device, in the United States in July 2012 and is leveraging its platform technology to build a comprehensive and proprietary portfolio of micro-scale injectable therapies designed to address the complete range of glaucoma disease states and progression. The company believes the iStent, measuring 1.0…

Continue Reading

MondayMar 13, 2017 12:30 pm

Five9, Inc. (NASDAQ: FIVN) Starts Presentation at 29th Annual ROTH Conference

Five9 (NASDAQ: FIVN) is a provider of cloud software for the enterprise contact center market, bringing the power of the cloud to thousands of customers and facilitating more than 3 billion customer interactions annually. Since 2001, Five9 has been a part of the cloud revolution in contact centers, helping organizations transition from legacy premise-based solutions to the cloud. Five9 provides businesses with reliable, secure, compliant, and scalable cloud contact center software designed to create exceptional customer experiences, increase agent productivity, and deliver tangible business results. For more information, visit the company’s website at www.five9.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation…

Continue Reading

Contact us: 212.418.1217